This is a request to continue a K05 Senior Scientist Award to permit the candidate to continue his career development in drug abuse research. During the past 15 years as a K02/K05 awardee the candidate has spent 80-85% of his time engaged in drug abuse research. His overall research goals employ multidisciplinary approaches to study the neurobiological bases of reinforcement, polydrug abuse, sex-related differences and novel pharmacotherapies for drug and alcohol abuse. The research plan is based on three currently funded R01 grants and a likely T32 Training grant on which the candidate is the Principal Investigator. The Career Development plan for the next five years will include 1) conducting research and acquiring new skills (80%), 2) mentoring (10%), 3) CPDD (5%), 4) Responsible Conduct of Research (5%). Currently funded projects are well stocked with a variety of brain imaging protocols to enhance the value of the information learned from the studies. Such ventures require a great deal of collaboration with other scientists at McLean. Mentoring the next generation of scientists is aimed primarily at the K23/K25 level but if the candidate's T32 is awarded he will take on postdoctoral trainees as well. The College on Problems of Drug Dependence (CPDD) is the major scientific organization dedicated to the study of drug abuse and as Chair of the Program Committee (and now candidate for president-elect) the candidate will continue to play a major role in the future development of the field. As Chair of McLean's IRB the candidate is responsible for monitoring the ethical conduct of all human research protocols at the hospital. Further, the candidate directs a monthly seminar series on the Responsible Conduct of Research for postdoctoral fellows, K-awardees, junior scientists and senior scientists. The candidate has made a strong commitment to drug abuse research and actively collaborates with junior and senior scientists to conduct the variety of protocols. Over the next five years he will study the effects of drug-related cues on brain function of adolescents and adults using brain electrical activity and fMRI, evaluate nicotine patches and citicoline as novel pharmacotherapies for cocaine abuse, and evaluate the utility of a Chinese herbal medicine, kudzu, as a possible treatment for alcohol abuse. The present application is being sought to provide the candidate with continued stability of support essential for his sustained commitment to research in the field of drug abuse and to ensure his continued level of productivity not only as a senior scientist, but as a mentor for the next generation of drug abuse scientists.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Scientist Award (K05)
Project #
3K05DA000343-10S2
Application #
7677763
Study Section
Special Emphasis Panel (ZDA1-KXA-N (17))
Program Officer
Gordon, Harold
Project Start
1997-08-01
Project End
2009-08-31
Budget Start
2006-09-01
Budget End
2009-08-31
Support Year
10
Fiscal Year
2008
Total Cost
$121,500
Indirect Cost
Name
Mclean Hospital
Department
Type
DUNS #
046514535
City
Belmont
State
MA
Country
United States
Zip Code
02478
Plante, David T; Trksak, George H; Jensen, J Eric et al. (2014) Gray matter-specific changes in brain bioenergetics after acute sleep deprivation: a 31P magnetic resonance spectroscopy study at 4 Tesla. Sleep 37:1919-27
Issa, Mohammed A; Narang, Sanjeet; Jamison, Robert N et al. (2014) The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for pain. Clin J Pain 30:472-8
Lukas, Scott E (2014) New perspectives on using brain imaging to study CNS stimulants. Neuropharmacology 87:104-14
Lindsey, Kimberly P; Bracken, Bethany K; Maclean, Robert R et al. (2013) Nicotine content and abstinence state have different effects on subjective ratings of positive versus negative reinforcement from smoking. Pharmacol Biochem Behav 103:710-6
Lukas, Scott E; Penetar, David; Su, Zhaohui et al. (2013) A standardized kudzu extract (NPI-031) reduces alcohol consumption in nontreatment-seeking male heavy drinkers. Psychopharmacology (Berl) 226:65-73
Bracken, B K; Trksak, G H; Penetar, D M et al. (2012) Response inhibition and psychomotor speed during methadone maintenance: impact of treatment duration, dose, and sleep deprivation. Drug Alcohol Depend 125:132-9
Penetar, David M; Looby, Alison R; Ryan, Elizabeth T et al. (2012) Bupropion reduces some of the symptoms of marihuana withdrawal in chronic marihuana users: a pilot study. Subst Abuse 6:63-71
Penetar, David M; Lindsey, Kimberly P; Peters, Erica N et al. (2012) Decreasing Nicotine Content Reduces Subjective and Physiological Effects of Smoking. Tob Use Insights 5:1-9
Puffer, Eve S; Skalski, Linda M; Meade, Christina S (2012) Changes in religious coping and relapse to drug use among opioid-dependent patients following inpatient detoxification. J Relig Health 51:1226-38
Licata, Stephanie C; Penetar, David M; Ravichandran, Caitlin et al. (2011) Effects of daily treatment with citicoline: a double-blind, placebo-controlled study in cocaine-dependent volunteers. J Addict Med 5:57-64

Showing the most recent 10 out of 38 publications